Background illustration for clinical trials search

Paid Clinical Trials Indianapolis

Discover 901 paid clinical trials in Indianapolis, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck

for
Squamous Cell Carcinoma, Nonmelanoma Skin Cancer,
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT05108090

Recruiting

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

for
Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8
Location: Indianapolis IN, Carmel IN, Chicago IL, Warrenville IL,
Sponsor: NRG Oncology

Sex: Female

Age: 18+

Code: NCT05646316

Phase 3, Recruiting

Exercise in Metastatic Breast Cancer: EMBody

for
Breast Cancer, Indolent Metastatic Breast Cancer
Location: Indianapolis IN, Boston MA
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT05468034

Recruiting

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

for
Large Cell Lymphoma, Diffuse, Relapsed Cancer,
Location: Indianapolis IN, Detroit MI, Charlottesville VA,
Sponsor: Dipenkumar Modi

Sex: All

Age: 18+

Code: NCT05852717

Phase 2, Recruiting

Evaluating Disparities in Precision Oncology

for
Metastatic Cancer, Advanced Cancer
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT06081517

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

DPX-Survivac and Pembrolizumab With and Without Intermittent Low-Dose Cyclophosphamide, in Subjects With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

for
Relapsed Diffuse Large B-cell Lymphoma,
Location: Indianapolis IN, Toledo OH, Pittsburgh PA, Atlanta GA,
Sponsor: ImmunoVaccine Technologies, Inc. (IMV Inc.)

Sex: All

Age: 18+

Code: NCT04920617

Phase 2, Recruiting

Adjuvant Pembrolizumab vs Observation Following Curative Resection for Stage I Non-small Cell Lung Cancer (NSCLC) With Primary Tumors Between 1-4 cm

for
NSCLC, Stage I
Location: Indianapolis IN, Chicago IL, Columbus OH, Madison WI,
Sponsor: Greg Durm, MD

Sex: All

Age: 18+

Code: NCT04317534

Phase 2, Recruiting

A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL

for
Relapsed Hodgkin Lymphoma, Refractory Hodgkin Lymphoma,
Location: Indianapolis IN
Sponsor: Rita Assi

Sex: All

Age: 18+

Code: NCT06484920

Phase 2, Recruiting

Biorepository: Indiana Health Study

for
Coronary Artery Disease, Heart Disease, Healthy
Location: Indianapolis IN, Indianapolis (South) IN,
Sponsor: Fairbanks Institute

Sex: All

Age: 18+

Code: NCT00741416

Recruiting

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

for
Metastatic Colorectal Carcinoma,
Location: Indianapolis IN, Carmel IN, Lexington KY, Chicago IL,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT05863195

Phase 3, Recruiting

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

for
Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8,
Location: Indianapolis IN, Avon IN, Carmel IN, Greenville OH,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06498635

Phase 3, Recruiting

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

for
Graft-versus-host Disease (GVHD)
Location: Indianapolis IN, Columbus OH, Ann Arbor MI, St Louis MO,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06615050

Phase 3, Recruiting

Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

for
Small Cell Lung Cancer
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT05889546

Recruiting

Evaluating Tolerability of ePUHRT With Brachytherapy Boost

for
Prostate Cancer
Location: Indianapolis IN
Sponsor: Indiana University

Sex: Male

Age: 18+

Code: NCT06817668

Recruiting

A Trial to Find Out if Odronextamab Combined With Lenalidomide is Safe and Works Better Than Rituximab Combined With Lenalidomide in Adult Participants With Follicular Lymphoma and Marginal Zone Lymphoma

for
Relapsed/Refractory Follicular Lymphoma,
Location: Indianapolis IN, Waukesha WI, Hattiesburg MS,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06149286

Phase 3, Recruiting

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

for
Urinary Bladder Neoplasms, Neoplasm Metastasis,
Location: Indianapolis IN, Cincinnati OH, Chicago IL, Columbus OH,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT05614739

Phase 1, Recruiting

Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers

for
Metastatic Breast Cancer, Triple Negative Breast Cancer,
Location: Indianapolis IN, Carmel IN, Lexington KY, Atlanta GA,
Sponsor: Kathy Miller

Sex: All

Age: 18+

Code: NCT05846789

Phase 2, Recruiting

CD4CAR for CD4+ Leukemia and Lymphoma

for
T-cell Lymphoma, T-cell Leukemia
Location: Indianapolis IN, New York NY, Houston TX, Miami FL
Sponsor: Huda Salman

Sex: All

Age: 12+

Code: NCT03829540

Phase 1, Recruiting

Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatment of Muscle-invasive Bladder Cancer

for
Muscle Invasive Bladder Urothelial Carcinoma
Location: Indianapolis IN, Philadelphia PA, New York NY,
Sponsor: Matthew Galsky

Sex: All

Age: 18+

Code: NCT06809140

Phase 2, Recruiting

Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma

for
Anemia, Iron Deficiency, Melanoma
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT06508827

Phase 2, Recruiting